A number of recent trials have explored potential strategies for using immunotherapy in chronic lymphocytic leukemia (CLL).

Shares of Cartesian Therapeutics climbed after the company announced positive results in a phase 2b trial of its lead cell-therapy candidate. The stock was up 8.3% to $15.60 in morning trading Tuesday ...

The global CD Antigen Cancer Therapy Market is valued at USD 27.5 Billion in 2024 and is projected to reach a value of USD 54 ...

Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) hit a new 52-week low during mid-day trading on Monday . The company traded as low as $29.31 and last traded at $30.15, with a volume of ...

Equities research analysts at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report released on Tuesday. The firm set a “hold” rating on the ...

Fate Therapeutics, Inc.’s FATE share price has surged by 10.29%, which has investors questioning if this is right time to ...

The real-world safety profile of tisagenlecleucel appears to be more favourable than that reported in the JULIET study, which led to its FDA approval.

Artiva Biotherapeutics, Inc.’s ARTV share price has surged by 32.38%, which has investors questioning if this is right time ...

Celyad Sa otc ( ($CLYYF) ) has released its Q4 earnings. Here is a breakdown of the information Celyad Sa otc presented to its investors. Celyad ...

Gov. Josh Green has announced a $10 million grant to further cancer care on Oʻahu for Queen’s Medical Center - West Oʻahu and ...

The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell ...